Brian Powl

Insider Reports History

Location
C/O Fate Therapeutics, Inc., 12278 Scripps Summit Drive, San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Brian Powl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Powl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kura Oncology, Inc. Chief Commercial Officer Common Stock 140K $1.56M $11.18 Nov 14, 2025 Direct
FATE THERAPEUTICS INC Chief Commercial Officer Stock Option (Right to Buy) 425K $1.16M $2.73 Feb 6, 2023 Direct
FATE THERAPEUTICS INC Chief Commercial Officer Common Stock 41.1K $180K $4.37 Jul 5, 2023 Direct
Kura Oncology, Inc. Chief Commercial Officer Option to purchase common stock 92.5K Jan 2, 2025 Direct

Insider Reports Filed by Brian Powl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KURA Kura Oncology, Inc. Nov 13, 2025 2 -$99.3K 4 Nov 14, 2025 Chief Commercial Officer
KURA Kura Oncology, Inc. Sep 27, 2025 2 -$79.5K 4 Sep 29, 2025 Chief Commercial Officer
KURA Kura Oncology, Inc. Jan 28, 2025 1 -$12.5K 4 Jan 28, 2025 Chief Commercial Officer
KURA Kura Oncology, Inc. Jan 2, 2025 2 $0 4 Jan 6, 2025 Chief Commercial Officer
KURA Kura Oncology, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Commercial Officer
KURA Kura Oncology, Inc. Aug 14, 2023 1 $0 4 Aug 16, 2023 Chief Commercial Officer
KURA Kura Oncology, Inc. Aug 14, 2023 0 $0 3 Aug 16, 2023 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Jul 5, 2023 1 -$18.8K 4 Jul 6, 2023 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Feb 6, 2023 1 $0 4 Feb 7, 2023 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Jun 27, 2022 2 $0 4 Jun 29, 2022 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Jun 27, 2022 0 $0 3 Jun 29, 2022 Chief Commercial Officer